📰 Given Inmode News
Given Inmode News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Inmode. Real-time updates on events, politics, business and more.
November 13, 2023
Nova Eye Medical (OTCMKTS:ELXMF – Get Free Report) and InMode (NASDAQ:INMD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation. Insider & Institutional Ownership 12.4% of Nova Eye […]
August 10, 2023
InMode (NASDAQ:INMD – Get Free Report) and Yubo International Biotech (OTCMKTS:YBGJ – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, valuation, earnings and institutional ownership. Valuation & Earnings This table compares InMode and […]
June 10, 2023
Endonovo Therapeutics (OTCMKTS:ENDV – Get Rating) and InMode (NASDAQ:INMD – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Analyst Ratings This is a summary of current recommendations and price […]
May 25, 2023
InMode (NASDAQ:INMD – Get Rating) and GigCapital5 (NYSE:GIA – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Analyst Ratings This is a breakdown of recent recommendations and price targets […]
May 23, 2023
GigCapital5 (NYSE:GIA – Get Rating) and InMode (NASDAQ:INMD – Get Rating) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, risk, dividends and profitability. Analyst Ratings This is a breakdown of current ratings for […]